20 results
20-F/A
2023 FY
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
of such a subsidiary.
DIVERSITY OF THE BOARD OF DIRECTORS
Board Diversity Matrix (As of March 25, 2024)
Country of Principal Executive Offices
Israel
Foreign
6-K
EX-99
BLRX
Bioline Rx Ltd
23 Jun 23
Notice of Annual General Meeting of Shareholders
4:16pm
that are not exercisable within 60 days of June 20, 2023.
See footnotes (1)-(13) for certain information regarding beneficial ownership.
DIVERSITY OF THE BOARD … OF DIRECTORS
Board Diversity Matrix (As of June 20, 2023)
Country of Principal Executive Offices
Israel
Foreign Private Issuer
Yes
Disclosure Prohibited under
6-K
EX-99
BLRX
Bioline Rx Ltd
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm
knowledge, no other person who we know beneficially owns 5.0% or more of the Company’s ordinary shares outstanding as of May 26, 2022.
DIVERSITY … OF THE BOARD OF DIRECTORS
Board Diversity Matrix (As of May 26, 2022)
Country of Principal Executive Offices
Israel
Foreign Private Issuer
Yes
Disclosure
20-F/A
bg51utaq
23 Mar 15
Annual report (foreign) (amended)
12:00am
424B3
87tz czkyliu07
8 Aug 13
Prospectus supplement
12:00am
424B3
zdoj75ky4 r1jb
15 Oct 12
Prospectus supplement
12:00am
F-1
2gu ayyu0o0g46ro
2 Oct 12
Registration statement (foreign)
12:00am
424B3
vxsc65lhdiq6rtb
28 Mar 12
Prospectus supplement
12:00am
20-F
5o8ypwqr
22 Mar 12
Annual report (foreign)
12:00am
20FR12B/A
n8la6mpygc
15 Jul 11
Initial registration of securities (foreign private issuers) (amended)
12:00am
20FR12B
v8hwif hm16h3fudnpb
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
F-1
pk1rld5xqvmy2nu
24 Sep 10
Registration statement (foreign)
12:00am
- Prev
- 1
- Next